drugset / Trial / NCT01302899
To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
RandomizedCrossoverSingle-blindTreatment
Summary
The study is designed to primarily assess the effect of aliskiren on albuminuria in patients with non-diabetic nephropathy when treated with ramipril and volume intervention.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-12
- Completion
- 2011-12
Outcome
Outcome not reported
Stopped: “In consequence of termination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aliskiren | Small molecule | 300 mg | — |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | — |
| Background | Ramipril | Small molecule | 10 mg | — |
Indications
No indication recorded.